Company news
XBiotech Inc. news in 2019
XBiotech Inc.'s news releases, calls and decks from 2019, newest first.
XBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen
December 29, 2019
XBiotech Added to NASDAQ Biotechnology Index
December 16, 2019
XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen
December 6, 2019
XBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with Hidradenitis Suppurativa
November 18, 2019
XBiotech Announces First Patient Enrolled in Placebo-Controlled Clinical Study Evaluating Its anti-IL-1⍺ Therapy Bermekimab in Patients with Atopic Dermatitis (Eczema)
November 11, 2019
XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa
October 22, 2019
XBiotech Announces First Patient in Clinical Study to Evaluate Bermekimab in Systemic Sclerosis
October 1, 2019
XBiotech Announces Oral Presentation of Atopic Dermatitis Results for Bermekimab at 2019 EADV Congress in Madrid, Spain
September 26, 2019
XBiotech Announces Granting of Canadian Patent for Treatment of Dermatological Pathologies
September 19, 2019